Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 173 for “"MGMT"”.
-
Veränderungen im MGMT-Status von humanen Glioblastomzelllinien
… epigenetisch determinierte Methylierungsgrad des MGMT-Genpromotors. Die Bestimmung des MGMT-Status gehört bei allen Patienten mittlerweile zur Standarddiagnostik, um den Effekt der Radiochemotherapie auf den Tumor zu prognostizieren. Ist der MGMT-Genpromotor unmethyliert, haben alkylierende …
-
ATF5-Expression und MGMT-Promotormethylierungsänderungen in glialen Tumoren
… der O6-Methylguanin-DNA-Methyltransferase (MGMT) ist ein etablierter Marker in der Therapie des GBMs. Sie ist mit dem therapeutischen Ansprechen auf Temozolomid und dem Überleben assoziiert. Uns fielen inzidentell Veränderungen der MGMT-Promotormethylierung auf, woraufhin wir den aktuellen …
-
THE ROLE OF ACTIVE AND ACTIVE-SITE ALKYLATED HUMAN O6-METHYLGUANINE-DNA METHYTRANSFERASE (MGMT AND R-MGMT) IN DNA REPAIR AND BIOMONITORING
… antibodies raised against recombinant human MGMT were characterized and used to study the role of active and active-site alkylated human O6-methylguanine-DNA methyltransferase (MGMT and R-MGMT) in DNA repair and biomonitoring. The human DNA repair enzyme O6-methylguanine-DNA methyltransferase …
-
Antiangiogene Therapie in Kombination mit Temozolomid beim experimentellen MGMT-methylierten Glioblastom
Simultane kombinierte TMZ/SU führt zu einer verbesserten Tumorkontrolle durch additive antiangiogene und synergistische proapoptotische Effekte. Die gesteigerte therapeutische Effektivität von kombinierter TMZ/SU-Therapie wird nur durch kontinuierliche gemeinsame Applikation, nicht jedoch durch …
-
Gewebebasierte Evaluation von Biomarkern am Beispiel von RCCma, MGMT, CXCR4 und HER2
… solider Tumoren einen methylierten MGMT-Promotor als mögliche Basis zur Prädiktion eines Benefits mit alkylierenden Chemotherapeutika wie Temozolomid. Wir konnten zeigen, dass der Chemokinrezeptor CXCR4 eine tumorbiologische Relevanz in Magen- und kolorektalen Karzinomen hat. …
-
The Expression of MGMT and Ku80 in Primary Central Nervous System Lymphoma and Prognostic Significance
… unsatisfactory therapy and poor prognosis. MGMT is one of the most important factors determining drug resistance while Ku80 determining radiosensitivity, the expression of MGMT and Ku80 in PCNSL remains unclear. The aim of our study was to detect the expression of MGMT and Ku80 on PCNSL by …
-
The Expression and Significance of MGMT, Ku80 and Ki67 Gene in Different Grades of Spinal gliomas
… to be associated with a survival advantage. MGMT is one of the most important genetic factors determining drug resistance while Ku80 determining radiosensitivity, and Ki67 determining tumor proliferation. The expression of MGMT, Ku80 and Ki67 in spinal glioma remains unclear. If they …
-
Μελέτη μεθυλίωσης των γονιδίων SOX17, MGMT και MLL3 σε Κυκλοφορούντα Καρκινικά Κύτταρα ασθενών με πρώιμο καρκίνο του προστάτη
… CpG νησίδων των υποκινητών των γονιδίων SOX17, MGMT και MLL3 στα CTCs. Τα συγκεκριμένα γονίδια επιλέχθηκαν λόγω της ογκοκατασταλτικής τους δράσης. Τα CTCs έχουν απομονωθεί μέσω του in vivo συστήματος ανίχνευσης CellCollectorTM (Gilupi). Όλα τα δείγματα που συνελέγησαν in vivo αναλύθηκαν …
-
Human DNA repair enzyme O6-Methylguanine-DNA Methyltransferase in cellular regulation upon DNA damage
… DNA adducts are repaired by the repair protein MGMT (O6-methylguanine-DNA-methyltransferase). MGMT protein is conserved through evolution but the exact physiological function remains obscure. MGMT acts by transferring the O6-alkyl group to the cysteine residue at position 145 at its active site. …
-
Epigenetic characterisation of the 06 methyl-guanine DNA-methyltransferase promoter in New Zealand melanoma cell lines : a thesis presented to Massey University in partial fulfillment of the requirements for the degree of Master of Science in Biochemistry at Massey University, Palmerston North, New Zealand
… enzyme O6 methyl-guanine methyltransferase (MGMT) is thought to be largely responsible for TMZ resistance. MGMT protects the cell from the effects of TMZ by removing cytotoxic lesions placed on the DNA. Mechanisms of regulation of MGMT expression remain unclear in melanoma. DNA methylation at …
-
The role of 5-methylcytosine in the expression of O(6)-methylguanine DNA-methyltransferase
… enzyme O6-methylguanine DNA methyltransferase (MGMT) is of clinical interest and provides a gene model for the study of CpG methylation's role in transcriptional regulation. Expression of MGMT is important to the maintenance of genomic integrity because it repairs O6-alkylguanine DNA lesions, …
-
IN VITRO AND IN VIVO CHARACTERIZATION OF MAMMALIAN O6-METHYLGUANINE-DNA METHYLTRANSFERASE
… a 22kDa O6-methylguanine-DNA methyltransferase (MGMT) which contains a conserved active site with a unique cysteine residue acting as the alkyl acceptor. Despite extensive homology in sequences surrounding the active site, the N-termini of mammalian methyltransferases differ significantly but arc …
-
Redox-based repurposed drugs as potent and rational inhibitors of the human DNA repair protein MGMT for increased efficacy of anticancer alkylating agents
MGMT (06-Methylguanine-DNA methyltransferase) is an antimutagenic DNA repair protein that maintains genomic stability through a direct reversal of alkylation damage in a stoichiometric reaction. It is highly expressed in human gliomas and other cancers, and paradoxically, its protective function …
-
Protocadherin gamma-C3 Knockout in Glioblastomzellen
… Die O6-Methylguanin-Methyltransferase (MGMT) ist ein Reparaturenzym, das zu TMZ-Resistenz führt. In MGMT-negativen GBM-Zellen konnte TMZ die Proliferation, Migration und Zellviabilität reduzieren, eine gesteigerte Apoptose (über Bax, Caspase-3 und PARP) auslösen und eine Reduktion der …
-
NEW ADVANCES IN QUANTITATIVE RADIOLOGY: RADIOMICS IN NEURORADIOLOGY APPLIED TO PRIMARY BRAIN TUMORS USING A MACHINE LEARNING APPROACH
… radiomics analysis to predict IDH mutation and MGMT methylation status in gliomas Fabio M. Doniselli1,2, Riccardo Pascuzzo1, Eleonora Bruno3, Domenico Aquino1, Mattia Verri, Alberto Redolfi, Valeria Cuccarini1, Marco Moscatelli1,2, Maria Grazia Bruzzone1, Luca Maria Sconfienza2,4 Abstract …
Page 1 of 9